Brian Curran Healy

Early Predictors of Clinical and MRI Outcomes Using LASSO in Multiple Sclerosis.

Bose G, Healy BC, Lokhande HA, Sotiropoulos MG, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttman CRG, Bakshi R, Weiner HL, Chitnis T.

Ann Neurol. 2022 Apr 15. PMID: 35429009

Determining the Incidence of Asymptomatic SARS-CoV-2 Among Early Recipients of COVID-19 Vaccines (DISCOVER-COVID-19): A Prospective Cohort Study of Healthcare Workers Before, During and After Vaccination.

North CM, Barczak A, Goldstein RH, Healy BC, Finkelstein DM, Ding DD, Kim A, Boucau J, Shaw B, Gilbert RF, Vyas T, Reynolds Z, Siddle KJ, MacInnis BL, Regan J, Flynn JP, Choudhary MC, Vyas JM, Laskowski K, Dighe AS, Lemieux JE, Li JZ, Baden LR, Siedner MJ, Woolley AE, Sacks CA.

Clin Infect Dis. 2022 Apr 09. 74(7):1275-1278. PMID: 34363462

MicroRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance.

Fujiwara M, Raheja R, Garo LP, Ajay AK, Kadowaki-Saga R, Karandikar SH, Gabriely G, Krishnan R, Beynon V, Paul A, Patel A, Saxena S, Hu D, Healy BC, Chitnis T, Gandhi R, Weiner HL, Murugaiyan G.

J Clin Invest. 2022 Mar 17. PMID: 35298438

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis.

Bjornevik K, Cortese M, Healy BC, Kuhle J, Mina MJ, Leng Y, Elledge SJ, Niebuhr DW, Scher AI, Munger KL, Ascherio A.

Science. 2022 01 21. 375(6578):296-301. PMID: 35025605

Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.

Lokhande H, Rosso M, Tauhid S, Chu R, Healy BC, Saxena S, Barro C, Paul A, Polgar-Turcsanyi M, Anderson M, Glanz BI, Kropshofer H, Granziera C, Leppert D, Kappos L, Kuhle J, Weiner HL, Bakshi R, Chitnis T.

Mult Scler J Exp Transl Clin. 2022 Jan-Mar. 8(1):20552173211069348. PMID: 35035990

Demand with low supply: A pipeline for personalized integrative medicine in multiple sclerosis.

Manglani HR, Healy BC, Vranceanu AM.

Mult Scler Relat Disord. 2022 Feb. 58:103493. PMID: 35030367

An Adaptive, Algorithm-based Text Message Intervention to Promote Health Behavior Adherence in Type 2 Diabetes: Treatment Development and Proof-of-Concept Trial.

Celano CM, Massey C, Long J, Kim S, Velasquez O, Healy BC, Wexler DJ, Madva EN, Huffman JC.

J Diabetes Sci Technol. 2021 Dec 15. 19322968211065067. PMID: 34911398

Patient-reported outcomes associated with transition to secondary progressive multiple sclerosis.

Healy BC, Zurawski J, Chitnis T, Weiner HL, Glanz BI.

Qual Life Res. 2021 Nov 16. PMID: 34783972

Myeloid cell subsets that express latency-associated peptide promote cancer growth by modulating T cells.

Gabriely G, Ma D, Siddiqui S, Sun L, Skillin NP, Abou-El-Hassan H, Moreira TG, Donnelly D, da Cunha AP, Fujiwara M, Walton LR, Patel A, Krishnan R, Levine SS, Healy BC, Rezende RM, Murugaiyan G, Weiner HL.

iScience. 2021 Nov 19. 24(11):103347. PMID: 34820606

Altered adipokine levels are associated with dimethyl fumarate treatment in multiple sclerosis patients.

Baharnoori M, Wilson R, Saxena S, Gonzalez CT, Sotiropoulos MG, Keyhanian K, Healy BC, Chitnis T.

Mult Scler Relat Disord. 2021 Nov. 56:103311. PMID: 34655958